Why common cancer drugs work differently than previously thought

Credit: Unsplash+

Chemotherapy has long been a standard treatment for cancer, with researchers believing that certain drugs, known as microtubule poisons, halt the division of cancer cells.

However, a recent study from the University of Wisconsin–Madison challenges this conventional understanding.

It suggests that these drugs, instead of stopping cell division entirely, alter the process, potentially leading to the death of cancer cells and regression of the disease.

Microtubule Poisons and Their Role

Microtubule poisons have been used to treat cancer by interfering with cell division. The assumption was that they arrested the division of cancer cells, preventing them from multiplying uncontrollably.

This belief was rooted in laboratory studies that demonstrated this effect.

The University of Wisconsin–Madison study, led by Beth Weaver and Mark Burkard, reveals a different perspective.

Published in the journal PLOS Biology, the research suggests that microtubule poisons, particularly paclitaxel (known by the brand name Taxol), work not by stopping mitosis but by disrupting it.

Mitosis is the process by which cells divide and produce new cells. In normal cell division, chromosomes are duplicated, and the identical sets move to opposite ends of the cell in a process called chromosomal segregation.

This migration is facilitated by the mitotic spindle, which is composed of microtubules.

The study found that microtubule poisons, including paclitaxel, induce abnormal divisions in cells. Instead of the usual two poles in the mitotic spindle, these drugs lead to the formation of three, four, or even five poles during mitosis.

Consequently, chromosomes are attracted in more than two directions, resulting in a scrambled genome.

This abnormal chromosomal segregation can lead to the loss of at least 20% of a cell’s DNA content, making it highly likely to die.

Therefore, while cancer cells continue to divide after exposure to microtubule poisons, the abnormal division process induced by these drugs can ultimately lead to the death of cancer cells.

Implications for Cancer Treatment

These findings have significant implications for cancer treatment and drug discovery.

While microtubule poisons are effective for many patients, researchers have been working to develop new therapies that mimic the believed mechanism of these drugs—stopping cell division.

However, past efforts in this direction have faced frustrating challenges.

The research by Weaver and her team suggests that focusing on disrupting mitosis and making chromosomal segregation worse might be a more promising approach.

The study highlights the need for a shift in perspective within the scientific community when it comes to understanding the action of cancer drugs.

In Conclusion

This study challenges the conventional wisdom surrounding the mechanism of certain cancer drugs. It sheds light on how microtubule poisons work differently than previously thought and offers new insights into the potential for developing more effective cancer treatments.

By understanding the true action of these drugs, researchers may be better equipped to explore innovative approaches to combat cancer and improve patient outcomes.

If you care about cancer, please read studies about a new method to treat cancer effectively, and this low-dose, four-drug combo may block cancer spread.

For more information about cancer prevention, please see recent studies about nutrient in fish that can be a poison for cancer, and results showing this daily vitamin is critical to cancer prevention.

The research findings can be found in PLOS Biology.

Follow us on Twitter for more articles about this topic.

Copyright © 2023 Knowridge Science Report. All rights reserved.